Acumen Pharmaceuticals(us:ABOS)
1.08
-1.82%
Updated on 2025-04-02
Open:1.10
Close:1.08
High:1.13
Low:1.06
Prev Close:1.10
Volume:234738.00
Turnover:255366.36
Turnover Ratio:0.39%
Shares:60.57M
MarketCap:65.12M
About Acumen Pharmaceuticals
Acumen Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which discovers and develops medicines and diagnostics for Alzheimer's disease. The company was founded by William L. Klein, Grant A. Krafft, and Caleb Finch in 1996 and is headquartered in Charlottesville, VA.
Company Name: Acumen Pharmaceuticals
Address: 427 Park Street
Employees: 52
Fiscar Year: 12-31
IPO Date: 2021-07-01
Website: http://www.acumenpharm.com
CIK: 1576885
View all SEC Filings
About
Acumen Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which discovers and develops medicines and diagnostics for Alzheimer's disease. The company was founded by William L. Klein, Grant A. Krafft, and Caleb Finch in 1996 and is headquartered in Charlottesville, VA.
Address:427 Park Street
Website:http://www.acumenpharm.com
Market Movers